The Silvio O. Conte Center at the University of Washington is designed with a specific goal of understanding how stress-exposure can exacerbate depressive symptoms and increase the risk of a depressive episode in vulnerable individuals. Clinical experience has established a strong interaction between a history of unregulated stress exposure and the risk of mood disorders, but how the stress- mediators produce enduring changes in brain function that result in depressive symptoms is not clear. Novel therapeutics based on new insights to these mechanisms have the potential to enhance stress-resilience in this vulnerable population.
The research aims of this Center are designed to understand 1) how the dynorphins, which are released in response to repeated stress, cause aversive effects in mice that have been suggested to be responsible for a component of stress-induced dysphoria in humans; 2) how the serotonergic inputs from the dorsal raphe nucleus (DRN) that regulate the dopaminergic system in the ventral tegmental area (VTA) affect neuronal excitability and are changed by repeated social defeat stress exposure; 3) how stress exposure alters gene expression in the serotonergic neurons of the DRN; and 4) how repeated stress exposure alters the regulation by CRF of the dopamine release by VTA neurons projecting to the nucleus accumbens (NAc). These studies in mice will combined the use of transgenic Cre driver lines, conditional gene inactivation, optogenetics, and DREADD techniques to selectively regulate specific components of the DRN-> VTA -> NAc neuronal circuit known to be important in mood regulation. The studies will use behavioral, electrophysiological and fast-scan voltammetry techniques to measure the responses mediated by the different components of the circuit. Both male and female mice will be studied to identify sex-specific responses. The Center will include translational studies that attempt to link the mouse studies to stress responses in Women with treatment-resistant depression. A plausible hypothesis underlying this clinical study component is that the inflammatory mediators affecting gene expression in peripheral blood lymphocytes may also be acting as stress-mediators in brain. For example, both cytokines and dynorphins regulate the serotonin transporter function, and a link between their effects on neuronal circuits may suggest novel therapeutic approaches. The UW-Conte Center will support basic science and clinical research, as well as community Outreach and Training missions in a coordinated and synergistic mode.

Public Health Relevance

The proposed Center is designed to engage a highly productive group of investigators in a novel and coordinated manner to address how stress exposure exacerbates clinical depression symptoms and precipitates depressive episodes in vulnerable individuals. Combining both human and mouse studies, the investigators will gain a better mechanistic understanding of the effects of stress on mood and cognition. Novel therapeutic treatments for depression based on these new insights on stress-resilience would be extremely beneficial.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH106428-03
Application #
9238509
Study Section
Special Emphasis Panel (ZMH1-ERB-L (01))
Program Officer
Winsky, Lois M
Project Start
2015-04-01
Project End
2020-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
3
Fiscal Year
2017
Total Cost
$1,335,180
Indirect Cost
$461,888
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Song, Allisa J; Palmiter, Richard D (2018) Detecting and Avoiding Problems When Using the Cre-lox System. Trends Genet 34:333-340
Abraham, Antony D; Fontaine, Harrison M; Song, Allisa J et al. (2018) ?-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition. Neuropsychopharmacology 43:362-372
Abraham, Antony D; Schattauer, Selena S; Reichard, Kathryn L et al. (2018) Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion. J Neurosci 38:8031-8043
Jo, Yong S; Heymann, Gabriel; Zweifel, Larry S (2018) Dopamine Neurons Reflect the Uncertainty in Fear Generalization. Neuron 100:916-925.e3
Schattauer, Selena S; Land, Benjamin B; Reichard, Kathryn L et al. (2017) Peroxiredoxin 6 mediates G?i protein-coupled receptor inactivation by cJun kinase. Nat Commun 8:743
Chung, Amanda S; Miller, Samara M; Sun, Yanjun et al. (2017) Sexual congruency in the connectome and translatome of VTA dopamine neurons. Sci Rep 7:11120
Li, Junwei; Baird, Madison A; Davis, Michael A et al. (2017) Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine. Nat Biomed Eng 1:
Rodeberg, Nathan T; Sandberg, Stefan G; Johnson, Justin A et al. (2017) Hitchhiker's Guide to Voltammetry: Acute and Chronic Electrodes for in Vivo Fast-Scan Cyclic Voltammetry. ACS Chem Neurosci 8:221-234
Geisheker, Madeleine R; Heymann, Gabriel; Wang, Tianyun et al. (2017) Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains. Nat Neurosci 20:1043-1051
Sanford, Christina A; Soden, Marta E; Baird, Madison A et al. (2017) A Central Amygdala CRF Circuit Facilitates Learning about Weak Threats. Neuron 93:164-178

Showing the most recent 10 out of 14 publications